MeSH tree: C23.550.835
Strapped to a stretcher in the back of an ambulance, the shooting victim moaned, then screamed. Blood splattered across the person's cheeks and neck, seeped through the gauze looped around a leg and dripped onto the floor.
Jan 5, 2026
0
0
The U.S. Food and Drug Administration has approved a new indication for Breyanzi (lisocabtagene maraleucel) for treating adults with marginal zone lymphoma (MZL) who have failed treatment or relapsed after two or more prior ...
Dec 15, 2025
0
0
The chimeric antigen receptor (CAR) T cell therapy anitocabtagene autoleucel (anito-cel) continued to show strong results in treating relapsed/refractory multiple myeloma, according to new trial data from researchers at The ...
Dec 8, 2025
0
0
A systematic review and meta-analysis evaluated the association between corticosteroid therapy, mortality, and infectious complications in adults with severe non-COVID-19 pneumonia or acute respiratory distress syndrome (ARDS). ...
Dec 1, 2025
0
1
A multi-institutional research team has demonstrated how AI and machine learning can optimize therapy selection and dosing for septic shock, a life-threatening complication that is the leading cause of hospital deaths.
Nov 20, 2025
0
0
Starting their period is a big deal for adolescents. It marks a turning point in their lives where puberty becomes the new normal and change is happening all over their bodies. Undoubtedly, adolescents are going to have questions, ...
Nov 18, 2025
0
0
An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding interleukin 12 strategy that lets CAR-T cells treat prostate cancer in mice while curbing previously ...
A prospective study conducted at Avicenna University Hospital (Cadi Ayyad University) suggests that the plethysmographic perfusion index (PPI), a noninvasive parameter derived from pulse oximetry, can help identify fluid ...
Oct 22, 2025
0
0
Research led by Friedrich-Alexander-Universität Erlangen–Nürnberg provides evidence that teclistamab may offer therapeutic benefit for patients with severe forms of treatment-resistant autoimmune diseases.
The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration of tumors into major blood vessels that cause blood clots and multiorgan failure, a one-of-a-kind ...
Oct 16, 2025
0
74
